Analysis

Investor attention is firmly fixed on Sangamo Therapeutics as the company approaches several pivotal near-term events. The dual catalysts of...

The biopharmaceutical company Outlook Therapeutics is approaching a pivotal transition, moving from clinical development into the commercial phase. This shift...

The infrastructure powering artificial intelligence relies on a select group of critical suppliers. Lumentum has established itself as a vital...

Block Inc. is navigating a pivotal transformation in 2026, centered on leveraging artificial intelligence (AI) and organizational streamlining to significantly...

The European automotive sector's earnings season is gaining momentum, placing Porsche Automobil Holding SE squarely under the market's microscope. As...

Anthropic, the artificial intelligence company, has initiated legal proceedings to contest a decision by the U.S. Department of Defense that...

Following a precipitous decline of nearly 70% in its share price last year, financial technology giant Fiserv is embarking on...

This week, Viking Therapeutics' management is engaging directly with institutional investors at two separate events in Miami. The central topic...

UnitedHealth Group finds itself at a pivotal juncture, balancing shareholder returns with strategic flexibility as it undertakes a significant operational...

Geopolitical instability in the Middle East is once again acting as a potent catalyst for volatility across global oil markets....